Faraday Future reports liability drop, robotics sales record
Get Alerts FFAI Hot Sheet
Join SI Premium – FREE
Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) said its total liabilities fell from approximately $355 million at the end of Q3 2025 to approximately $230 million at the end of Q1 2026, according to a press release. The company said it plans to reduce total liabilities to below $100 million over the next three to four quarters.
The California-based company, which shifted its focus to robotics after its 2021 IPO and automotive strategy, said its EAI Robotics unit shipped 152 units in July, which it described as a monthly record. Cumulative sales and shipments reached 394 units through the end of July, against a stated full-year target of 2,000 units.
Faraday Future said it is launching a "Built in USA" initiative for its robotics business in three phases: localized implementation of software and AI systems, transitioning to U.S. assembly for hardware, and eventually achieving domestic manufacturing for certain components. The company cited recent Federal Communications Commission robotics policy as a factor in the timing of the initiative. It also said it is exploring plans for its Hanford, California manufacturing facility.
The company plans to hold an industry partner recruitment conference in two sessions. The first, on August 26, will target downstream partners including dealers, distributors, system integrators, and data partners. The second, on September 28, will focus on upstream partners including U.S.-based manufacturing, computing, and component suppliers.
The company noted in its forward-looking statements that it currently lacks the ability to pay its outstanding obligations, relies on Chinese manufacturers for all of its robotics products, and faces the possibility of a federal ban on Chinese robotics imports, among other risk factors.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Faraday Future stockholders approve $25M private placement proposal
- Birkenstock Holding (BIRK) Misses Q3 EPS by 2c; lifts guidance
- Spruce Biosciences (SPRB) PT Lowered to $144 at Citizens on Higher OpEx, Net Loss
Create E-mail Alert Related Categories
Corporate NewsRelated Entities
Bankruptcy, IPO, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share